Background: In lower- and middle-income countries across Asia there has been a rapid expansion and uptake of percutaneous coronary intervention (PCI). However, there has been limited routine collection of related data, particularly around quality, safety and cost. The aim of this study was to assess the viability of implementing routine collection of PCI data in a registry at a leading hospital in Hanoi, Vietnam.
Method: A Vietnamese data collection form and collection strategy were developed in collaboration with the Vietnam National Heart Institute. Information on patient characteristics, treatments, and outcomes was collected through direct interviews using a standardised form and medical record abstraction, while PCI data was read and coded into paper forms by interventional cardiologists. Viability of the registry was determined by four main factors: 1) being able to collect a representative sample; 2) quality of data obtained; 3) costs and time taken for data collection by hospital staff; and 4) level of support from key stakeholders in the institute.
Results: Between September 2017 and May 2018, 1,022 patients undergoing PCI were recruited from a total of 1,041 procedures conducted during that time frame. The estimated mean time to collect information from patients before discharge was 60 minutes. Of the collected data fields, 98% were successfully completed. Most hospital staff surveyed indicated support for the continuation of the activity following the implementation of the pilot study.
Conclusions: The proposed methodology for establishing a PCI registry in a large hospital in Vietnam produced high quality data and was considered worthwhile by hospital staff. The model has the potential opportunity for replication in other cardiac catheterisation sites, leading to a national PCI registry in Vietnam.
Coronary heart disease (CHD) is consistently the leading cause of death worldwide, responsible for approximately 16.6% of total deaths in 2016 and places a large economic burden on the population [1, 2]. Since its inception in 1977, percutaneous coronary intervention (PCI) has been recognised as a valuable procedure for treating CHD patients and has become a common part of routine practice worldwide [3, 4]. The Asia-Pacific region is home to nearly 60% of the world’s population, where CHD is now a leading cause of mortality [5, 6] and the development of PCI registries is of growing interest [7, 8, 9]. As a clinical quality registry, a PCI database is an important mechanism for monitoring and benchmarking the performance of clinical care, improving safety and outcomes, contributing to reducing treatment cost and regulating guidelines [10, 11]. Nonetheless, there remains wide geographic variation in terms of the organisation, operation, management, sustainability and utilisation of data collected of PCI registries in Asia. Additionally, data are limited regarding the participation of less economically developed countries, particularly those in the South-East Asia region, including Vietnam [9, 12, 13, 14].
As a nation undergoing rapid economic and epidemiological transition, Vietnam has experienced a high burden of CHD, causing more than 58,000 deaths (11.6% of all mortality) in 2017 . Vietnam began to adopt PCI in 1995 at the Vietnam National Heart Institute (VNHI), and has to date introduced this procedure to approximately 70 cardiac centres nationwide . The annual number of PCI procedures is relatively large and increasing; for instance, there were 2,250 patients receiving this technique in 2013 in a single national centre and there is a 15% increase annually . Notwithstanding its widespread use, there has been no PCI registry in Vietnam.
This paper presents the rationale, design and conduct of a pilot PCI registry model in Vietnam. The viability of implementing routine collection of PCI data was also assessed and documented. If viable, this would be the initial step in developing a model for an expanded PCI registry in Vietnam. The major objectives of this pilot study are 1) to describe the implementation experience at a large cardiac centre in Vietnam; 2) to describe the methodology for developing the PCI registry in Vietnam; and 3) to report on the viability of the strategy as a model for the nation.
This PCI pilot registry project was conducted at the VNHI. Located in Hanoi, the capital city of Vietnam, VNHI is the biggest cardiac and referral centre in the country, providing the highest quality of healthcare services for cardiovascular patients in the country. Numerous advanced catheter-based therapies including complex coronary stenting, aortic stent grafting, transcatheter cardiac structural interventions, have become integrated into routine clinical practice at VNHI. As a 450-bed medical institution, VNHI receives around 17,000 inpatients and 80,000 out-patients annually, from across Northern Vietnamese provinces. The number of cardiac interventional procedures undertaken at VNHI is increasing from approximately 2,800 in 2004 to 12,000 in 2018 . In addition, VNHI is an education and training centre, from which cardiovascular technologies and therapies are transferred into practice at other lower level medical institutions. VNHI was therefore selected for implementing the pilot PCI registry to reflect the contemporary practice of PCI in Vietnam.
This study adapted the current versions of standardised data abstraction forms developed for the Victorian Cardiac Outcomes Registry (VCOR), Australia , including the standard case report form (CRF) and dataset definitions for all fields. The state-wide VCOR was built on the Melbourne Interventional Group registry , in which PCI data elements are in line with a number of current interventional registries worldwide, for instance, the American College of Cardiology – National Cardiovascular Data Registry . The standard dataset aimed to collect the minimum standard data and avoid cumbersome management:
The VCOR data collection forms were translated into Vietnamese, and revised by two Vietnamese clinical cardiologists to reflect local practice. After discussion, consensus was reached around the addition of some new elements into the Vietnamese data collection forms, such as patient details (e.g. medical record number, ethnic group, poverty status, educational level, occupation, and income) and risk factors (e.g. smoking, dyslipidaemia).
The Vietnamese data collection forms were designed in the TELEFORM software  and printed in paper records. The specific questions for all three data collection points are presented in the Appendix.
Following the finalisation of the data collection form, data recruitment commenced in September 2017. Potential participants were patients who underwent PCI at VNHI during the study period and met the following criteria: (1) Vietnamese residents aged 18 years and over; (2) Had at least one active phone contact number; and (3) Able to communicate, understand the information sheet and did not opt-out of future follow-ups by the time of discharge. There were no exclusion criteria. Under the strict clinical audit and strategy for data collection, baseline data collection was conducted over a 9 month period (from September 2017 to May 2018), followed by the 30-day follow-up, while the 12-month follow-up is underway.
Baseline data were collected using a paper-based form through interviewing patients, visiting the catheterization laboratory where PCI was performed and extracting information from medical records. The data manager at VNHI and research assistants were responsible for conducting these activities. Compliance with the project protocol was supervised by staff trained in clinical audit processes. The patient interviews were largely conducted in wards, following the index PCI and prior to discharge when patients were medically well enough, as assessed by the responsible physician. Data on the index PCI (e.g. the PCI indication, entry location, adjunctive devices, lesion characteristics, in-stent restenosis, stent thrombosis, and stents used) were obtained from the catheterization laboratory. Images of coronary lesions were stored on protected disks, and printed, read and coded by a cardiologist. Other information was abstracted from medical records including time of admission, in-hospital management, medications used, clinical tests and pre-discharge complications (e.g. renal impairment, cardiogenic shock, bleeding [classified by the Bleeding Academic Research Consortium (BARC)]) , stroke, new or current myocardial infarction, target vessel or lesion revascularisation after the procedure (PCI or coronary artery bypass grafting). It took approximately one hour to complete a CRF on average.
The 30-day and 12-month follow-up surveys were designed to capture data on the combined endpoint of major adverse cardiac and/or cerebrovascular events such as all cases of death, new or recurrent myocardial infarction or stent thrombosis, target vessel revascularisation or stroke; bleeding (BARC) ; rehospitalisation; medication use and health quality of life (mobility, personal care, usual activities, pain/discomfort, anxiety/depression, and own health state today) of participants after the index PCI.
At 30 days, a face-to-face interview was conducted by the data manager or research assistants if the participant was physically present at VNHI; otherwise, a phone interview was used. Supplementary information from a heart ultrasound and blood tests was recorded during the face-to-face interviews at VNHI, which lasted approximately 30 minutes.
The 12-month follow-up survey is beyond the scope of the current report, however the planned methods are as follows. A 15-minute phone interview is being undertaken by trained research assistants to obtain information from the patients directly. First-degree relatives are used as the proxy if the participant is not contactable. At least three attempts will be made to contact the participants. If patients have additional concerns regarding their health, then consultation will be available upon request following the interview.
We also conducted an online survey with qualitative open-ended questions to explore perspectives on the implementation of the registry and identify key factors associated with successful implementation of this new model at VNHI. We approached all clinical, nursing and leadership staff involved in coronary interventional activity. The survey that contained 10 questions was administered using Qualtrics Research Suite (Qualtrics, Provo, UT), a web-based tool that allows researchers to build, distribute, and analyse online surveys in real time. Analysis of qualitative data was guided by the principles of the conventional and summative content analysis . Briefly, responses obtained from participants were coded to identify and categorise different themes together with performing word counts. The interpretation focused on the several key factors that may influence the development and implementation of PCI registry in Vietnam.
This is the first study focusing on developing a model to collect data on the contemporary practice of PCI at the largest cardiac institute in Vietnam. The viability of the pilot PCI registry as a model for a national registry in Vietnam was determined by the following elements:
Ethics for the study was approved by the Curtin University Human Research Ethics Committee (HRE 2017-0378). Every participant was provided with a Patient Information Sheet in which the purpose of the study, activities and rights of participants were described clearly. Participating in this study was voluntary and participants had the right to decline their participation or withdraw from the study at any time without any consequence via an ‘opt-out’ consent. A unique ID was assigned to each participant and linkable to the private information such as name, age, address, and phone numbers for follow- ups. All information that identifies participants was coded and stored confidentially.
During the study period (from September 2017 to May 2018), patients who underwent PCI at VNHI and met the inclusion criteria were approached and invited to take part in the study. Three strategies were used to enrol patients as the pilot study progressed, with changes applied to recruitment and the corresponding results (Figure 1). The modification of the data collection strategy was implemented to ensure that, in the absence of resources to capture all cases, we were able to capture a representative sample and minimise the potential for selection bias in registry enrolment when a single data manager was responsible.
For the first period of data collection (September and October 2017), 6–7 patients were randomly selected from the total number admitted of each day. However, to eliminate the potential bias of choosing only good prognosis patients (i.e., without complications prior to and after the procedure), we moved to second approach (from November 2017 to March 2018) which aimed to collect all cases in two weekdays. Two particular weekdays (Monday and Tuesday) were chosen to capture data from all operators including two teams of interventionists who performed PCI at VNHI on alternate days during the week. Notably, this second period of data collection coincided with Tet (Lunar New Year’s holiday), the biggest cultural event in the year, which may explain a reduction in the number of patient visits. The actual number of patients recruited in the period one and three may be generalizable to the rest of the year (i.e., from June to August) because there were no similar events in the year. Finally, the last period (from April to mid-May 2018) included all patients undergoing PCI on two weekdays and the weekend, which was designed to capture both the normal practice (weekdays) and acute cases (weekend).
A total of 1,028 eligible coronary patients were approached and invited from a total of approximately 2,800 patients undergoing PCI at VNHI during the study period. Six patients refused to participate in the study by opt-out consent and thus 1,022 patients remained in the baseline study sample, which included 1,041 individual PCIs (as 19 patients underwent PCI twice at VNHI). There was an extremely high rate of data completeness, with only information of one lesion missed due to a lost disk (0.1%). Ninety-eight percent of fields were fully filled, with the exception of oral anti-coagulant therapy as patients had difficulty recognising the kinds of drug used and unknown information about their referral to cardiac rehabilitation. The successful follow-up rate at 30 days was high, with 993 patients followed-up (97.2%).
Of the 25 invited cardiovascular professionals, 12 consented to participate in the qualitative survey (response rate: 48%). These 12 respondents included 5 cardiologists with administrative leadership at VNHI, 3 clinical cardiologists and 4 nurses. Several key additional factors concerning the successful implementation of a PCI registry in Vietnam were raised. Nine respondents agreed with the importance of standardised data collection forms as used in the registry. Other key facilitating factors were also emphasized, including well-trained investigators, the use of professional clinical audit, and strong support from leaders of target cardiac institutions. They also raised concerns regarding the sustainability of such a study at VNHI, including lack of data storage systems, sufficient funding for infrastructure and human resources, and strong commitment from hospital leaders.
The viability of the pilot PCI registry in VNHI was determined by the following elements:
In the context of the growing interest in developing clinical quality registries worldwide, this paper reports the development of the first PCI registry in Vietnam, using and adapting experiences from longstanding registries in Australia [19, 25]. The work to date has demonstrated a PCI registry to be feasible and suitable for Vietnamese circumstances, providing a significant opportunity to extend the approach to other cardiac centres looking to replicate the model. Importantly, implementing such a model not only provides crucial feedback on the performance of PCI for Vietnamese clinicians and cardiac care providers but also allowing a robust comparison with other regional registries such as those involved in the ASPECT collaboration  as well as contributing to the literature on the use of PCI.
In comparison with other regional PCI registries in Thailand, China, India and Malaysia, the methodology in our pilot registry had some similarities, including using a standard abstraction form to collect consecutive patients undergoing PCI, providing sufficient training for investigators prior to data collection, performing clinical audit to ensure data quality and conducting follow-ups at 30 days and 12 months to investigate the outcomes of PCI [8, 9, 12, 13]. Nonetheless, due to resource constraint, we did not approach all the patients undergoing PCI in the study period. The CRF was also completed in a paper format only and data obtained were not transferred to a web based system as other PCI registries [8, 9, 12]. Therefore, further studies might apply our methodology if there is limited resources or overcome our drawbacks if there is sufficient funding.
Although it is at an early stage, we are optimistic about the viability of the PCI model that we have implemented at the VNHI. The success of the PCI registry at the VNHI to date, is due to a variety of key factors such as the high number of patients undergoing PCI and their strong engagement with clinicians, the availability of data resources, and the supportive hospital staff team. We also faced several challenges in the first registry implement at VNHI, including high workload which might affect the time spent on data collection by the hospital staff and the lack of electronic record systems which made it difficult to collect comprehensive information when patients revisited the hospital. However, these obstacles can be minimised by providing sufficient training for clinical investigators, specifying sections of the data forms for investigators and conducting more detailed follow-up surveys.
One limitation is that the registry was conducted at VNHI, the leading cardiac centre in Vietnam where there is a highest patient throughput. Therefore, extending the methodology in establishing PCI registries in smaller settings with potentially less experienced staff may require a modified approach to that which we have done, but we believe this current work represents an important first step in doing so. Another potential concern may be bias in data collection, though attempt was made to enrol a representative sample. Thus, where sufficient resources are available, collecting all patients undergoing PCI in the study period would be recommended.
This paper describes the methodology of establishing the first PCI registry at the leading cardiac centre in Vietnam and reports on the viability of this model. We hope that the successful implementation of a PCI registry at VNHI will encourage other cardiac intervention centres in Vietnam to adopt this model in their daily practice and by doing so, enables the opportunity to develop a nationwide PCI registry.
The additional file for this article can be found as follows:Appendix
PCI Form 1 – Baseline. DOI: https://doi.org/10.5334/gh.782.s1
|ASPECT||Asia Pacific Evaluation of Cardiovascular Therapies|
|BARC||Bleeding Academic Research Consortium|
|CHD||Coronary heart disease|
|CRF||Case reported form|
|PCI||Percutaneous coronary intervention|
|VCOR||Victorian Cardiac Outcomes Registry|
|VNHI||Vietnam National Heart Institute|
We wish to thank the Victorian Cardiac Outcomes Registry for their kind agreement for the adoption of data collection materials, including the abstraction forms and definitions. We wish to also thank the Vietnam Nation Heart Institute for providing us with the opportunity to conduct the pilot registry and the facilities related to the study.
This research received partial financial support from Curtin University, Australia.
The first author, HTTV, is supported by a joint PhD scholarship awarded by the Vietnamese Ministry of Education and Training and Curtin University, Australia.
The authors have no competing interests to declare.
World Health Organization. Health statistics and information systems. Disease burden, 2000–2016. http://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html. (Accessed 2017).
Thomas H, Diamond J, Vieco A, Chaudhuri S, Shinnar E, Cromer S, et al. Global Atlas of Cardiovascular Disease 2000–2016: The Path to Prevention and Control. Glob Heart. 2018; 13(3): 143–63. DOI: https://doi.org/10.1016/j.gheart.2018.09.511
Kumar S, Walters TE, Halloran K, Morton JB, Hepworth G, Wong CX, et al. Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia. Europace. 2013; 15(12): 1702. DOI: https://doi.org/10.1093/europace/eut162
Ahmad WAW, Ali RM, Zambahari R, Ismail O, Yan LC, Bang LH, et al. Highlights of the first Malaysian National Cardiovascular Disease Database (NCVD): Percutaneous Coronary Intervention (PCI) Registry. CVD Prevention and Control. 2011; 6(2): 57–61. DOI: https://doi.org/10.1016/j.cvdpc.2011.02.006
World Health Organization. Health statistics and information systems. Cause – specific mortality, 2000–2016. http://www.who.int/healthinfo/global_burden_disease/estimates/en/. (Accessed 2016).
Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol. 2013; 168(2): 934–45. DOI: https://doi.org/10.1016/j.ijcard.2012.10.046
Ahmad WA, Ali RM, Khanom M, Han CK, Bang LH, Yip AF, et al. The journey of Malaysian NCVD-PCI (National Cardiovascular Disease Database-Percutaneous Coronary Intervention) Registry: A summary of three years report. Int J Cardiol. 2013; 165(1): 161–4. DOI: https://doi.org/10.1016/j.ijcard.2011.08.015
Jabir A, Mathew A, Viswanathan S, Ashraf SM, Sebastian P, Parsannakumar CK, et al. The design and rationale of the primary angioplasty registry of Kerala. Indian Heart J. 2017; 69(6): 777–83. DOI: https://doi.org/10.1016/j.ihj.2017.05.025
Krittayaphong R, Boonbaichaiyapruck S, Kiatchoosakun S, Piamsomboon C, Chotinaiwattarakul C, Kunjara-Na-Ayudhya R, et al. Demographics and Outcomes of Percutaneous Coronary Intervention in Thailand: Data from Thai Percutaneous Coronary Intervention Registry. J Med Assoc Thai. 2017; 100(3): 270–9.
McNeil JJ, Evans SM, Cameron PA, Johnson NP. Clinical-quality registries: Their role in quality improvement. Medical Journal of Australia. 2010; 192(5): 244–5. DOI: https://doi.org/10.5694/j.1326-5377.2010.tb03499.x
Gliklich RE, Dreyer NA, Leavy MB, Christian JB (eds.). 21(st) Century Patient Registries: Registries for Evaluating Patient Outcomes: A User’s Guide: 3(rd) Edition, Addendum. Rockville, MD: Agency for Healthcare Research and Quality (US); 2018. DOI: https://doi.org/10.23970/AHRQREGISTRIESEBOOK
Liew HB, Rosli MA, Wan Azman WA, Robaayah Z, Sim KH, Investigators NP. The foundation of NCVD PCI Registry: The Malaysia’s first multi-centre interventional cardiology project. Med J Malaysia. 2008; 63 Suppl C: 41–4.
Li J, Dharmarajan K, Li X, Lin Z, Normand SL, Krumholz HM, et al. Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) retrospective study of coronary catheterisation and percutaneous coronary intervention. BMJ Open. 2014; 4(3): e004595. DOI: https://doi.org/10.1136/bmjopen-2013-004595
Reid CM, Yan B, Wan Ahmad WA, Bang LH, Hian SK, Chua T, et al. The Asia-Pacific Evaluation of Cardiovascular Therapies (ASPECT) collaboration-Improving the quality of cardiovascular care in the Asia Pacific region. Int J Cardiol. 2014; 172(1): 72–5. DOI: https://doi.org/10.1016/j.ijcard.2013.12.030
World Health Rankings. Vietnam: Coronary Heart Disease. 2017. https://www.worldlifeexpectancy.com/viet-nam-coronary-heart-disease.
Thai NQ. The efficacy of intervetional coronary of drug eluting stents in patients with acute myocardial infarction. Hanoi: Hanoi Medical University; 2012.
Vietnam National Heart Institue. Vietnam National Heart Institute: 28 years development (1989–2017) http://vientimmach.org.vn/. (Assessed 2017).
Victorian Cardiac Outcomes Registry. Annual Public Report. Victoria, Australia; 2013.
Stub D, Lefkovits J, Brennan AL, Dinh D, Brien R, Duffy SJ, et al. The Establishment of the Victorian Cardiac Outcomes Registry (VCOR): Monitoring and Optimising Outcomes for Cardiac Patients in Victoria. Heart Lung Circ. 2018; 27(4): 451–63. DOI: https://doi.org/10.1016/j.hlc.2017.07.013
Ajani AE, Reid CM, Duffy SJ, Andrianopoulos N, Lefkovits J, Black A, et al. Outcomes after percutaneous coronary intervention in contemporary Australian practice: Insights from a large multicentre registry. Med J Aust. 2008; 189(8): 423–8. DOI: https://doi.org/10.5694/j.1326-5377.2008.tb02113.x
Electric Paper. TeleForm: Automated Document Solution. 2017. http://www.electricpaper.biz/products/teleform.html.
Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation. 2011; 123(23): 2736–47. DOI: https://doi.org/10.1161/CIRCULATIONAHA.110.009449
Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005; 15(9): 1277–88. DOI: https://doi.org/10.1177/1049732305276687
Vietnam National Heart Institue. The report of staff’s income at Vietnam National Heart Institute in 2018. 2018.
Ajani AE, Szto G, Duffy SJ, Eccleston D, Clark DJ, Lefkovits J, et al. The foundation and launch of the Melbourne Interventional Group: A collaborative interventional cardiology project. Heart Lung Circ. 2006; 15(1): 44–7. DOI: https://doi.org/10.1016/j.hlc.2005.08.001